174 related articles for article (PubMed ID: 31703755)
21. Deciphering the effective combinatorial components from Si-Miao-Yong-An decoction regarding the intervention on myocardial hypertrophy.
Chen XY; Chen XH; Li L; Su CP; Zhang YL; Jiang YY; Guo SZ; Liu B
J Ethnopharmacol; 2021 May; 271():113833. PubMed ID: 33465437
[TBL] [Abstract][Full Text] [Related]
22. Baoyuan decoction (BYD) attenuates cardiac hypertrophy through ANKRD1-ERK/GATA4 pathway in heart failure after acute myocardial infarction.
Meng H; Du Z; Lu W; Wang Q; Sun X; Jiang Y; Wang Y; Li C; Tu P
Phytomedicine; 2021 Aug; 89():153617. PubMed ID: 34157504
[TBL] [Abstract][Full Text] [Related]
23. YQWY Decoction Improves Myocardial Remodeling via Activating the IL-10/Stat3 Signaling Pathway.
Li H; Gong ZJ; He Y; Huang JJ; Jiang YN; Liu YY; Zhu Y; Jiang WM
Evid Based Complement Alternat Med; 2020; 2020():7532892. PubMed ID: 33456490
[TBL] [Abstract][Full Text] [Related]
24. TFEB insufficiency promotes cardiac hypertrophy by blocking autophagic degradation of GATA4.
Song R; Lei H; Feng L; Cheng W; Li Y; Yao LL; Liu J
J Biol Chem; 2021 Oct; 297(4):101189. PubMed ID: 34517007
[TBL] [Abstract][Full Text] [Related]
25. Shunxin decoction improves diastolic function in rats with heart failure with preserved ejection fraction induced by abdominal aorta constriction through cyclic guanosine monophosphate-dependent protein kinase Signaling Pathway.
Jiaying Z; Xiangxiang W; Xuefeng LI; Yang Y; Yinghuan D; Yanbin S; Ping X; Mengru Z; Junnan Z; Miao LI; Shuwen Z; Rui Z; Ying T; Hao T; Feifei T
J Tradit Chin Med; 2022 Oct; 42(5):764-772. PubMed ID: 36083484
[TBL] [Abstract][Full Text] [Related]
26. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
[TBL] [Abstract][Full Text] [Related]
27. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
[TBL] [Abstract][Full Text] [Related]
28. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
[TBL] [Abstract][Full Text] [Related]
29. [Zhenwu Decoction delays ventricular hypertrophy in rats with uremic cardiomyopathy].
Lai J; Wu Y; Hang L; Gael A; Deng T; Yan Q; Fu Q; Li Z
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):113-119. PubMed ID: 30692076
[TBL] [Abstract][Full Text] [Related]
30. Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway.
Yoon JJ; Son CO; Kim HY; Han BH; Lee YJ; Lee HS; Kang DG
Molecules; 2020 Dec; 26(1):. PubMed ID: 33374365
[TBL] [Abstract][Full Text] [Related]
31. The Role Played by Transcription Factor E3 in Modulating Cardiac Hypertrophy.
Rishiq A; Islam O; Golomb E; Gilon D; Smith Y; Savchenko I; Eliaz R; Foo RS; Razin E; Tshori S
Int Heart J; 2021 Nov; 62(6):1358-1368. PubMed ID: 34744144
[TBL] [Abstract][Full Text] [Related]
32. [Effect and mechanism of Linggui Zhugan Decoction in regulating Sig1R on AngⅡ-induced cardiomyocyte hypertrophy].
Wang X; Mo JJ; Tang TJ; Ding R; Huang JL
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):754-762. PubMed ID: 38621879
[TBL] [Abstract][Full Text] [Related]
33. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy.
Patel R; Nagueh SF; Tsybouleva N; Abdellatif M; Lutucuta S; Kopelen HA; Quinones MA; Zoghbi WA; Entman ML; Roberts R; Marian AJ
Circulation; 2001 Jul; 104(3):317-24. PubMed ID: 11457751
[TBL] [Abstract][Full Text] [Related]
34. Buyanghuanwu Decoction alleviated pressure overload induced cardiac remodeling by suppressing Tgf-β/Smads and MAPKs signaling activated fibrosis.
Chen H; Song H; Liu X; Tian J; Tang W; Cao T; Zhao P; Zhang C; Guo W; Xu M; Lu R
Biomed Pharmacother; 2017 Nov; 95():461-468. PubMed ID: 28865366
[TBL] [Abstract][Full Text] [Related]
35. Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-/- mice.
Mishra S; Bedja D; Amuzie C; Avolio A; Chatterjee S
Biochem Biophys Res Commun; 2015 Sep; 465(1):159-64. PubMed ID: 26253472
[TBL] [Abstract][Full Text] [Related]
36. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure.
Bisping E; Ikeda S; Kong SW; Tarnavski O; Bodyak N; McMullen JR; Rajagopal S; Son JK; Ma Q; Springer Z; Kang PM; Izumo S; Pu WT
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14471-6. PubMed ID: 16983087
[TBL] [Abstract][Full Text] [Related]
37. Shenfuqiangxin Capsule inhibits apoptosis through mitogen-activated protein kinase signal pathway in rats with cardio-renal syndrome induced by infrarenal aortic-clamping.
Wang L; Wang Z; Yuan L; Hao D; Lü N; Li X
J Tradit Chin Med; 2017 Feb; 37(1):80-7. PubMed ID: 29957913
[TBL] [Abstract][Full Text] [Related]
38. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
[TBL] [Abstract][Full Text] [Related]
39. Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway.
Wu JB; Zhou Y; Liang CL; Zhang XJ; Lai JM; Ye SF; Ouyang H; Lin J; Zhou JY
Chin J Integr Med; 2017 Oct; 23(10):770-778. PubMed ID: 27048408
[TBL] [Abstract][Full Text] [Related]
40. Mitogen-activated protein kinases pathways mediate the sunitinib-induced hypertrophy in rat cardiomyocyte H9c2 cells.
Korashy HM; Al-Suwayeh HA; Maayah ZH; Ansari MA; Ahmad SF; Bakheet SA
Cardiovasc Toxicol; 2015 Jan; 15(1):41-51. PubMed ID: 24984876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
